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To promote the biochemical reactions of life, cells can compartmen-
talize molecular interaction partners together within separated
non–membrane-bound regions. It is unknown whether this strategy
is used to facilitate protein degradation at specific locations within
the cell. Leveraging in situ cryo-electron tomography to image the
native molecular landscape of the unicellular alga Chlamydomonas
reinhardtii, we discovered that the cytosolic protein degradation ma-
chinery is concentrated within ∼200-nm foci that contact specialized
patches of endoplasmic reticulum (ER) membrane away from the ER–
Golgi interface. These non–membrane-bound microcompartments
exclude ribosomes and consist of a core of densely clustered
26S proteasomes surrounded by a loose cloud of Cdc48. Active
proteasomes in the microcompartments directly engage with pu-
tative substrate at the ER membrane, a function canonically
assigned to Cdc48. Live-cell fluorescence microscopy revealed that
the proteasome clusters are dynamic, with frequent assembly and
fusion events. We propose that the microcompartments perform
ER-associated degradation, colocalizing the degradation machinery
at specific ER hot spots to enable efficient protein quality control.
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The ubiquitin–proteasome system degrades both unwantedand misfolded proteins, playing a vital role in maintaining
proteostasis and regulating numerous processes throughout the
cell. Within the nucleus, proteasomes are often concentrated in
“degradation centers,” regions of high degradation capacity. In
mammalian cells, nuclear proteasomes can accumulate in non–
membrane-bound compartments called PML bodies (1). In
yeast, Drosophila S2 cells, and the green alga Chlamydomonas
reinhardtii, nuclear proteasomes accumulate at the periphery of
the nucleus (2–4), which in Chlamydomonas was shown to be
mediated by tethering proteasomes to the nuclear pore complex
(NPC) (5). However, it is unknown whether cytosolic protea-
somes also accumulate to form degradation centers. One hint
that cytosolic proteasomes might have specific cellular localiza-
tion is their requirement for the elimination of misfolded pro-
teins from the endoplasmic reticulum (ER).
Approximately one-third of the proteins in a eukaryotic cell
are synthesized by ER-bound ribosomes and inserted into either
the ER membrane or lumen (6, 7), where they are folded and
then trafficked through the secretory system to a variety of in-
tracellular and extracellular destinations. The accumulation of
misfolded proteins in the ER is toxic to the cell and underlies
numerous human diseases (8). Proteins that fail to be refolded by
ER-localized chaperones (9) are eliminated by an evolutionarily
conserved quality control pathway called ER-associated degrada-
tion (ERAD) (10–12). Misfolded proteins are retrotranslocated
to the cytosol and polyubiquitinated by the channel-forming E3
ligase Hrd1 (13, 14). The type II AAA+ segregase, Cdc48, is
recruited by Ubx2 to the ER membrane (15), where it is believed
to play a key role in pulling these polyubiquitinated substrates
away from the Hrd1 channels so that they can be degraded by
cytosolic 26S proteasomes (16–18). While the major players in
ERAD have been identified, little is known about how they are
spatially organized within the cell. Some ERAD proteins appear
to concentrate in a subcompartment of the mammalian ER (19),
and a fraction of cytosolic proteasomes may associate with the ER
membrane (3, 20). However, it remains a mystery whether ERAD
is performed uniformly throughout the ER network, or whether it
is coordinated in specialized regions.
To explore the cellular organization of the cytosolic ubiquitin–
proteasome system, we combined focused ion beam (FIB) mill-
ing (21–23) with cryo-electron tomography (cryo-ET) to directly
visualize macromolecules in situ, within the native cellular envi-
ronment (24). By imaging the model green alga Chlamydomonas
reinhardtii, which has conserved ERAD components (SI Appen-
dix, Figs. S1 and S2 and Table S1), modern genetic tools (25),
excellent cryo-EM contrast, and textbook organelle architecture
(26–28), we found that proteasomes and Cdc48 cluster together in
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non–membrane-bound microcompartments that contact the
ER membrane.
Results
To get an overview of proteasome localization withinChlamydomonas
cells, we expressed the proteasome subunit Rpn11 fused with the
fluorescent protein mVenus, and then examined live cells in three
dimensions (3D) by wide-field deconvolution microscopy. As
expected from our previous cryo-ET discovery that proteasomes
tether to NPCs (5), we observed a clear fluorescence signal along
the nuclear envelope (Fig. 1A). This localization confirms that the
Rpn11-mVenus protein was incorporated into functional protea-
somes. In addition, bright puncta could be seen in the cytoplasm
adjacent to the nucleus. These puncta were most commonly ob-
served between the basal side of the nucleus and the concave inner
surface of the cup-shaped chloroplast, a region of the cytoplasm
occupied by abundant ER and Golgi (Fig. 1 B and C). Cytosolic
puncta were observed in 78% of the population; cells most
frequently contained 0 to 3 puncta, with up to 6 puncta per cell
(Fig. 1D). The Rpn11-mVenus signal at the nuclear envelope
was ∼2.4-fold more intense than the cytoplasmic background
signal, whereas puncta intensity was more variable but on average
∼3.9-fold more intense than the background, indicating a higher
concentration of proteasomes in the puncta than at the nuclear
envelope (Fig. 1E).
Tracking the cytosolic puncta over time revealed that these
structures are dynamic. We recorded time series of living Rpn11-
mVenus cells with 3D Z stacks acquired once per minute. Despite
fairly rapid photobleaching, we observed the de novo assembly of
new cytosolic puncta in multiple cells during the 14-min time se-
ries (SI Appendix, Fig. S3 and Movie S1). The puncta often
appeared to assemble adjacent to the nuclear envelope and then
migrate outward toward the ER (SI Appendix, Fig. S3 B–D). Even
more striking, the cytosolic puncta appeared to fuse with each other
(SI Appendix, Fig. S4 and Movie S2). Before fusion, two puncta
often exhibited coupled motion (for example, see SI Appendix, Fig.
S4D). Immediately following fusion, the resulting single punctum
increased in fluorescence intensity, reflecting the accumulation
of Rpn11-mVenus from the two fused puncta within a diffraction-
limited spot. These puncta were observed to remain as single
entities for several minutes after fusion (up to 9 min of the 14-min
time series; see SI Appendix, Fig. S4C), suggesting the events were
bona fide fusion.
To investigate the molecular architecture of these cytosolic
proteasome foci, we visualized the native cellular environment in
3D by in situ cryo-ET (29). Because the small size and transient
nature of the fluorescent puncta made direct correlation between
fluorescence and cryo-ET unreliable, we instead examined the
distribution of proteasomes in nontransgenic Chlamydomonas
cells. Our search was aided by the exceptionally reproducible
cellular architecture of these algae, which restricted the protea-
some foci to a region around the nucleus that is rich in ER and
Golgi (Fig. 1 B and C). In 76 cellular tomograms covering both the
cytoplasm and nuclear periphery, cytosolic 26S proteasomes were
identified via template matching and subtomogram averaging, as
detailed in ref. 5. Mapping the proteasomes back into the cel-
lular environment revealed densely packed clusters of protea-
somes adjacent to the ER membrane (Fig. 2, SI Appendix, Figs.
S5–S7, and Movies S3 and S4). The clusters were located near
the ribosome-bound surface of the rough ER, away from the
ER’s specialized ribosome-free region that serves as an exit site
for COPII-mediated transport to the Golgi (Fig. 2D). Comparing
the proteasome positions to simulated random distributions of
proteasomes within the same cellular volumes confirmed the
clustering behavior (SI Appendix, Fig. S8A). Six clusters were dis-
tinguished from the rest of the cytosolic proteasome population by
k-means analysis, with 19 to 42 proteasomes per cluster.
Next, we sought to identify a second component of the ubiquitin–
proteasome system, the AAA-ATPase Cdc48 (homolog of mam-
malian p97). Template matching and subtomogram averaging
yielded a hexameric structure for Cdc48 (Fig. 2E and SI Appendix,
Fig. S9C) that resembles the single-particle cryo-EM structure (30,
31). Due to the small size of this 540-kDa complex, we took sev-
eral measures to ensure correct and comprehensive identification.
First, we thoroughly classified our candidate Cdc48 subvolumes to
discard false positives from the average (SI Appendix, Fig. S10).
Next, we successfully calculated reference-free averages, both with
and without imposed 6-fold symmetry, confirming that the sub-
volumes could reach a Cdc48 structure without directing the
alignment toward an initial reference (SI Appendix, Figs. S9A and
S11A) (32, 33). Even without imposing symmetry during align-
ment, the resulting average shows clear characteristics of a hex-
amer (SI Appendix, Fig. S11). This reference- and symmetry-free
average resembles a mixture of both ring (30, 31) and staircase
(34) conformational states (SI Appendix, Fig. S12). However, the
small size of Cdc48 prevented classification from distinguishing
these conformations, and thus, we were unable to separate the
complexes into subpopulations. Finally, we employed whole-cell
mass spectrometry to verify that there is a high concentration of
Cdc48 in our Chlamydomonas strain (Fig. 3) (35). Cdc48 and
proteasomes were detected with similar protein abundance, in
agreement with the distribution of the two complexes in our to-
mograms (Fig. 3C). Furthermore, Cdc48 was far more abundant
than the other common cytosolic type II AAA-ATPases, NSF and
Pex1/6 (Fig. 3B) (36). Thus, even if our structural analysis was
unable to distinguish between different species of type II AAA-
ATPases, the percentage of incorrectly assigned Cdc48 parti-
cles would be low. In addition to Cdc48, we also generated
subtomogram averages of both free and membrane-bound 80S ri-
bosomes (Fig. 2E and SI Appendix, Fig. S9D), as described in ref. 37.
Mapping the proteasomes, ribosomes, and Cdc48 structures
back into the cellular environment enabled us to draw several
conclusions. The proteasome clusters exclude ribosomes, both in
the cytosol as well as on the ER membrane; there are small
ribosome-void patches exactly at the spots where clusters touch the
membrane (Fig. 4 A and B and SI Appendix, Fig. S7). Principal-
component analysis (PCA) of all of the proteasome clusters in our
dataset revealed a slightly flattened, globular-shaped cloud with a
diameter of 210 ± 30 nm (first PCA axis) by 101 ± 29 nm (second
PCA axis) (Fig. 4C). Based on their shape, we determined the
centroid of each cluster and evaluated the radial protein concen-
tration from the centroid for proteasomes, Cdc48, and ribosomes
(Fig. 4D). The 30 to 40 μM concentration of densely packed
proteasomes at the cluster center is higher than the ∼8 μM pro-
teasome concentration we previously measured at the nuclear
envelope (5), consistent with our fluorescence intensity measure-
ments (Fig. 1E). We observed a clear separation between pro-
teasomes and ribosomes, with the latter’s concentration increasing
right at the cluster border to a constant cytosolic level. Cdc48,
however, was found throughout the proteasome cluster and sur-
rounding ribosome region, but its concentration peaked at the
periphery of the cluster, with a ∼5-fold increase compared to the
rest of the cytosol. To show that Cdc48 not only colocalizes with
the proteasome clusters but also clusters with them statistically, we
calculated the distances from each proteasome to each Cdc48
within the tomograms (Fig. 4E). This analysis was performed in-
dependently for proteasomes inside and outside the clusters, both
for the experimental data and for simulated data where the same
number of Cdc48 complexes were placed randomly throughout
the same cytosolic volumes. Whereas the distance distribution
of nonclustered cytosolic proteasomes to Cdc48 appeared random
(Fig. 4E, Right), there was a clear nonrandom peak at short distances
between clustered proteasomes and Cdc48 (Fig. 4E, Left), indicating
an accumulation of Cdc48 at the border of the proteasome cluster.
In agreement with this finding, a Kolmogorov–Smirnov test showed

























Fig. 1. In Chlamydomonas cells, proteasomes are concentrated at the nuclear envelope and in cytosolic puncta. (A) Live Chlamydomonas mat3-4 cells
expressing the tagged proteasome subunit Rpn11-mVenus, imaged in 3D by wide-field deconvolution fluorescence microscopy. Left column: maximum-
intensity projection of Rpn11-mVenus, showing localization to the nuclear envelope and cytosolic puncta. Middle column: Rpn11-mVenus (green) overlaid
with chlorophyll autofluorescence (magenta). Right column: both fluorescence signals overlaid on a bright-field image, with protruding flagella dis-
tinguishing the apical (api) and basal (bas) sides of the cell. (B) Transmission electron microscopy overview image of a Chlamydomonas cell thinned to
∼200 nm with a cryo-FIB. The nucleus, ER, Golgi, and chloroplast are pseudocolored as indicated. (C) Diagram of Chlamydomonas organelle architecture (Left;
colored as in B) and fluorescence localization from A (Right). The Rpn11-mVenus puncta are predominantly localized to the cytoplasm between the nucleus
and the chloroplast, a region occupied by ER and Golgi. (D) Histogram of the number of cytosolic puncta per cell. N = 565 cells. (E) The intensity of Rpn11-
mVenus fluorescence at the nuclear envelope and within the cytosolic puncta, normalized by fold change over each cell’s cytosolic background. Puncta have
nearly twice the intensity of the nuclear envelope, indicating higher proteasome concentration. Error bars show SD. (Scale bars: 2 μm in A and B.)
































with high statistical significance that the distances between clustered
proteasomes and their nearest Cdc48 neighbors were nonran-
dom (SI Appendix, Fig. S8B). In contrast, distance analysis between
proteasomes and ribosomes revealed no correlation (SI Appendix,
Fig. S8E). Taking these findings together, the proteasome clusters
define cytosolic microcompartments of distinct protein composition,
excluding ribosomes while concentrating proteasomes and Cdc48
together at a specialized patch of the ER membrane.
To gain more insight into the function of these ER-associated
microcompartments, we used classification to take a closer look
at the structures of the proteasomes contained within. Classifica-
tion can distinguish several features of proteasomes in situ, in-
cluding whether the 20S core particle is capped by one or two 19S
regulatory particles, and whether each 19S cap is in an inactive
ground state or an active substrate-processing state (5, 38, 39).
Our resolution was sufficient to clearly distinguish these struc-
tural differences for each proteasome. Interestingly, we saw an
increased percentage of double-capped proteasomes within the
clusters (80%) compared to the rest of the cytosol (61%) (Fig. 5A,
Top). Such an increased frequency of double-capped proteasomes
indicates a higher degradation capacity and was recently observed
for accumulated proteasomes within neurodegenerative aggre-
gates (39). In contrast, the proteasome caps showed very similar
substrate-processing state frequencies (19%) inside and outside
the clusters (Fig. 5A, Bottom). While this demonstrates that the
proteasomes within the microcompartments are active, we
further dissected the functional states of these clustered pro-
teasomes by analyzing the frequency of substrate-processing
19S caps as a function of distance from the ER membrane
(Fig. 5B). Immediately adjacent to the ER (<20 nm), we observed
a statistically significant higher percentage of substrate-processing
caps (50%). Averaging these ER-proximal proteasomes revealed
an extra density attached to their substrate-processing caps (Fig.
5B, Inset). In a previous in situ cryo-ET study by Guo et al. (39),
proteasomes with substrate-processing caps were observed to bind
poly-GA neurodegenerative aggregates. The subtomogram aver-
age of these proteasomes showed a large extra density bound
to the caps that clearly originated from the engaged aggregate. As
the 19S caps were in the substrate-processing state, and the gate to
the 20S proteolytic chamber was open, the extra density could be
definitively assigned to substrate that is being fed into the pro-
teasome. Comparing the structure from Guo et al. with our sub-
tomogram average of ER-proximal proteasomes revealed a clear
overlap of the extra densities at the proteasome’s substrate-
engagement site near Rpn1, indicating that the extra density we
observe is likely substrate (SI Appendix, Fig. S13). Upon mapping
the proteasomes and putative substrate densities back into the
cellular volumes, we found that the substrate densities always
originated from the ER membrane (Fig. 5C). Thus, proteasomes
inside the microcompartments are not only active, but their level
of activity is correlated with their proximity to the ER membrane,
with the closest proteasomes apparently pulling proteins directly
out of the membrane.
To further investigate the function of these ER-associated
proteasome clusters, we monitored the effects of pharmacological
treatments on the proteasome puncta seen by fluorescence micros-
copy (SI Appendix, Fig. S14). Treatment with the ER stress-inducing
drug tunicamycin had little effect on proteasome localization but
Fig. 2. Imaged with in situ cryo-ET, cytosolic proteasomes cluster at the ER membrane. (A) Slice through a tomogram that targets the cytoplasm of a
Chlamydomonas mat3-4 cell, showing the ER and the Golgi. (B and C) Two different Z slices through the proteasome cluster boxed in A. Red arrows, pro-
teasomes; yellow arrows, Cdc48 (Movie S4). (D) Corresponding segmentation (Golgi, dark gray; ER, light gray; other organelles, white) with in situ
subtomogram averages of proteasomes (red, 19.5-Å resolution), Cdc48 (yellow, 32.8-Å resolution), free cytosolic ribosomes (light blue, 18.8-Å resolution), and
membrane-bound ribosomes (dark blue, 21.9-Å resolution) mapped back into the cellular volume. (E) Enlarged views of the in situ subtomogram averages.
(Scale bars: 200 nm in A, 50 nm in B and C, and 10 nm in E.)

























moderately decreased the number of cytosolic puncta. One in-
terpretation could be that the proteasome puncta do not respond
to the acute misfolding of ER proteins but rather perform a
constitutive degradation function at the ER membrane. However,
because many of the cytosolic proteasomes were already clustered
within puncta before adding the drug, it is hard to conclude
much from the observation that additional puncta do not form.
Treatment with the proteasome inhibitor MG132 (40) also re-
duced the number of cytosolic puncta and caused a dramatic ac-
cumulation of bright proteasome puncta at the nuclear envelope.
This striking redistribution between proteasome populations war-
rants future study and may prove useful for dissecting the function
of NPC-tethered proteasomes. Treatment with the Cdc48 inhibitor
NMS-132 (41) appeared to be toxic to Chlamydomonas cells and
resulted in diffuse cytosolic proteasome signal.
Discussion
Combining live-cell fluorescence microscopy with in situ cryo-ET,
we observed that a significant fraction of cytosolic protein degra-
dation in Chlamydomonas is likely carried out within dynamic, non–
membrane-bound microcompartments that have their own charac-
teristic architecture (Fig. 6). These globular microcompartments
exclude ribosomes and consist of an inner core of active proteasomes
surrounded by a loose shell of Cdc48 (Fig. 4). Each micro-
compartment is positioned directly adjacent to a specialized patch
on the ER membrane that lacks membrane-bound ribosomes.
While our imaging approach could only clearly identify the
large cytosolic proteasome and Cdc48 complexes, it seems
plausible that the adjacent ribosome-free patch on the ER
membrane also has a distinct molecular composition. This small
membrane region, which matches the dimensions of the cyto-
solic microcompartment (Fig. 4 A and B and SI Appendix, Fig.
S7), may be enriched with both ERAD substrates and ER-resident
components of the ERAD pathway, such as E3 ligases and
retrotranslocation channels. By concentrating the cytosolic and
membrane-embedded ERAD machinery together into a few deg-
radation hot spots along the ERmembrane, the microcompartments
could greatly increase ERAD efficiency. The degradation micro-
compartments are localized away from the ER–Golgi interface, a
larger zone of ribosome exclusion that is enriched with mediators
of vesicular trafficking, such as coat proteins (27, 42). This seg-
regation of COPII budding and ERAD to different regions of
the ER may facilitate the sorting of ER proteins either for
onward traffic through the secretory pathway or for removal
and degradation (Fig. 6). The close association of degradation
microcompartments to the ER membrane may also explain the
Fig. 3. Whole-cell mass spectrometry shows that Cdc48 is the most abundant type II AAA-ATPase and confirms the relative abundance of complexes
identified by in situ cryo-ET. (A) Scatter plot of the proteome from Chlamydomonas mat3-4 cells (the same strain used for cryo-ET). Protein abundance is
plotted as intensity versus the iBAQ value (intensity-based absolute quantification; raw protein intensity divided by the number of peptides) (99). Measured
proteasome, ribosome, Cdc48, NSF, and Pex1/6 subunits are marked with red, blue, yellow, light green, and dark green circles, respectively. Note that because
Cdc48 and NSF form homo-hexamers, the number of macromolecular complexes is 6-fold lower than the protein abundance. Pex1 and Pex6 form a hetero-
hexamer, so the number of macromolecular complexes is 3-fold lower than the protein abundance. (B) The relative levels of 3 common cytosolic type II AAA-
ATPases from the whole-cell proteomics, normalized to Cdc48. (C) The relative levels of ribosome, proteasome, and Cdc48 complexes from the proteomics
(blue) and cryo-ET (orange). Error bars show SD (between subunits for the mass spectrometry and between tomograms for the cryo-ET). Concentrations are
normalized by the ribosome levels. The plot on the Right shows a zoom-in on the proteasomes and Cdc48 to more clearly display their relative abundance.
The slightly lower concentration of proteasomes determined by cryo-ET is likely due to the high abundance of proteasomes in the nucleus (5); in this analysis,
only cytosolic proteasomes were quantified by cryo-ET, whereas whole cells were measured by mass spectrometry.
































coupled motion we observed before two microcompartments
fuse (SI Appendix, Fig. S4 and Movie S2). These microcompart-
ments are likely bound to the same membrane, which would en-
able them to readily encounter each other and fuse.
One surprising observation is the direct engagement of pro-
teasomes with density that emanates from the ER membrane (Fig.
5C). Unlike NPC-tethered proteasomes, which are bound by a
tethering density at the Rpn9 subunit of their 19S cap (5), these
proteasomes bind the ER-emanating density on the opposite side
of their cap, near Rpn1. Two previous in situ studies have observed
putative substrate occupying this specific region (38, 39). In par-
ticular, the study by Guo et al. clearly shows that proteasomes with
caps in the substrate-processing conformational state bind neu-
rodegenerative aggregates at this Rpn1-adjacent region. Like the
aggregate-engaged proteasomes in Guo et al., the ER-engaged
proteasomes observed in our study are also in the substrate-
processing state and are also bound to density at the Rpt AAA-
ATPase ring near Rpn1 (Fig. 5B and SI Appendix, Fig. S13). Based
on this structural evidence, we conclude that the density attaching
these proteasomes to the ER is likely substrate that the protea-
somes are directly extracting from the membrane. Due to the direct
action of proteasomes on ER proteins, we term this mechanism
noncanonical “direct ERAD” (Fig. 6). In support of this mecha-
nism, there is evidence that the proteasome’s Rpt AAA-ATPase
can extract specific substrates from the ER (43–45). However, it
remains to be studied whether the direct ERAD we observe is
specific for a subset of ER-localized substrates. The rate-limiting
step for proteasome-mediated degradation is the mechanical
Fig. 4. Proteasomes and Cdc48 form globular ribosome-excluding microcompartments. (A and B) Two close-up views of proteasome clusters within the cell,
looking toward the ER membrane (gray) from the cytosol. Top image: view displaying proteasomes (red), Cdc48 (yellow), and ribosomes (membrane-bound,
dark blue; free, light blue). Bottom image: the same view with only the ribosomes displayed, revealing that ribosomes are excluded from the proteasome
cluster and adjacent patch on the ER membrane (red dashed line). (C) PCA of proteasome cluster shape. Left side: eigenvectors (3 shades of purple) are drawn
for a model circle and sphere (Top 2 rows), as well as an example cluster (Bottom row, red dots are proteasome center positions). Right side: the corresponding
ratio of eigenvalues for each shape, with SDs displayed as bidirectional arrows. N = 6 proteasome clusters (SI Appendix, Figs. S6 and S7). (D) Radial con-
centrations of proteasomes, Cdc48, and ribosomes outward from the centroid positions of the proteasome clusters reveal a cellular microcompartment of
distinct composition. Proteasomes are strongly accumulated in the microcompartment. Cdc48 are found throughout the cytosol but peak at the micro-
compartment border. Ribosomes are only found beyond the microcompartment border, reaching a constant concentration throughout the cytosol. The fairly
broad transition from proteasomes to ribosomes at the border is primarily due to combining microcompartments of different sizes (range of diameters on
long axis: 157 to 235 nm) for this analysis. Error bars show SD. (E) Distances from every proteasome to every cytosolic Cdc48, performed separately for cluster
proteasomes (Left plot, yellow) and noncluster proteasomes (Right plot, yellow). The analysis was repeated on simulated data where the same number of
Cdc48 complexes was randomly placed into the same cellular volumes (gray). The experimental data for the cluster proteasomes shows a nonrandom peak
at <200 nm, indicating that Cdc48 clusters together with proteasomes in the microcompartments.

























unfolding of substrates by the proteasome’s Rpt AAA-ATPase,
which could take minutes for well-folded substrates (46). Such a
long residency time of proteasomes engaged with ER substrates
would explain why we captured several of these events in our
tomograms.
Cdc48 is canonically described to function upstream of the
proteasome in the ERAD pathway, extracting misfolded proteins
from the ER membrane and delivering them to cytosolic protea-
somes for degradation (17, 18, 47). In the degradation micro-
compartments, we observed a loosely organized cloud of Cdc48
complexes around the cytosolic periphery of the proteasome
cluster instead of at the interface between the proteasomes and
the ER membrane (Fig. 4D, SI Appendix, Fig. S8C, and Movies S3
and S4). While at first glance this observation might seem to be
inconsistent with canonical Cdc48-mediated ERAD, quantifying
the distribution of proteasomes and Cdc48 along the whole ER
surface reveals a more compatible explanation: Of the complexes
within 200 nm of the ER membrane, 82% of the proteasomes but
only 20% of Cdc48 are found inside the microcompartments. It is
likely that the other 80% of ER-proximal Cdc48 performs ca-
nonical ERAD, segregating substrates from Hrd1 at dispersed
locations along the ER membrane and then diffusing through the
cytoplasm until the Cdc48 encounters a proteasome to degrade its
substrate. As the majority of ER-proximal proteasomes are clus-
tered within the microcompartments, diffusing Cdc48 would ac-
cumulate at the microcompartment periphery to hand substrates
to the proteasomes, completing the canonical ERAD pathway
(Fig. 6). The ATPase rate of Cdc48 is about 10 times faster than
the proteasome (46, 48), which suggests that Cdc48 may have a
shorter residency time at the ER. This would explain why we do
not observe accumulation of Cdc48 at the ER membrane (SI
Appendix, Fig. S8D). Given the high concentration of protea-
somes in the microcompartments, these regions may additionally
serve as hubs for the degradation of cytosolic proteins. Indeed,
quality control of cytosolic proteins has been shown to require
ER-resident ubiquitin ligases (49, 50), and thus may also occur
at the surface of the ER membrane.
Recent in vitro work suggests that Cdc48 may dock onto the
proteasome’s 20S core in place of the 19S regulatory cap (51). To
look for this interaction, we searched the tomograms with a hybrid
Cdc48-proteasome template structure (SI Appendix, Fig. S15).
Reference-free alignment of the top hits produced a normal 26S
proteasome structure, indicating that Cdc48-proteasomes are not
present in significant numbers within the cellular volumes. Indeed,
even though our approach attempted to bias the template
matching toward a Cdc48-proteasome hybrid structure, we none-
theless could only recover normal 26S proteasomes.
One question that remains for future investigation is the prev-
alence of degradation microcompartments in other organisms.
Much of the canonical ERAD pathway was elucidated through
extensive study of the budding yeast Saccharomyces cerevisiae
(10, 13, 16, 47, 52–55). Although most of the ERAD machinery is
conserved between yeast and Chlamydomonas (SI Appendix,
Figs. S1 and S2), the cellular architecture of the secretory
system is not. Chlamydomonas cells have an elaborate and
highly organized ER and Golgi, with a clearly defined interface
between the two organelles (26–28, 37). In contrast, the ER and
Golgi of S. cerevisiae have simplified architecture; the Golgi is
not stacked and appears to be randomly positioned relative to
the ER, lacking the robust interface region found in Chlamy-
domonas and mammalian cells (56, 57). Thus, S. cerevisiae may
lack this separation of protein degradation in microcompart-
ments away from the secretory traffic of the ER–Golgi in-
terface (Fig. 6).
How do the degradation microcompartments form, and how
are they anchored to the ER membrane? Some answers may be
Fig. 5. Analysis of proteasome states within degradation microcompartments. (A) Comparison of assembly state and functional state frequencies between
the cluster and noncluster cytosolic proteasomes. Cluster proteasomes have a higher percentage of double-capped (80%) compared to the cytosolic pop-
ulation (61%). For both populations, the majority of proteasome caps are in the ground state (69 to 74%). Double-capped, purple; single-capped, lavender;
ground state, green; substrate-processing state, pink; unclassified, gray. (B) Functional states of cluster proteasome caps as a function of distance to the ER
membrane. The percentages of processing caps are written in pink over each bar in the graph. Proteasomes <20 nm from ER have a significantly higher
fraction of processing caps compared to the rest of the cluster proteasomes (for statistical test, see Methods). Subtomogram averaging of these ER-proximal
proteasome caps reveals an extra density that likely corresponds to engaged substrate (dashed Inset, red: fitted proteasome molecular structure; see SI
Appendix, Fig. S13 for evidence that the extra density is bound at the proteasome’s substrate engagement site). (C) Mapping each of the ER-proximal
processing state proteasomes (red) back into the cellular volumes reveals that the extra density (orange) always connects to the ER membrane (gray),
consistent with a putative substrate.
































found in the composition of the ribosome-free patch of membrane
adjacent to the microcompartment, which may contain proteins
that help recruit proteasomes to the ER. It will be interesting to
investigate the parallels between this noncanonical direct ERAD
mechanism and canonical ERAD, where Cdc48 recruitment
and substrate engagement are mediated by Ubx2 and Hrd1,
respectively (13, 15, 54). As we only observed proteasome clusters
in contact with the ER membrane and not free-floating in the
cytosol, recruitment of proteasomes to the ER may nucleate
proteasome clustering.
Unlike the proteasomes tethered to NPCs that we observed in
an earlier study (5), the proteasomes within the microcompartments
are randomly oriented. Instead, the degradation microcompartments
seem to be more architecturally similar to proteasome storage
granules (PSGs), spherical non–membrane-bound proteasome
clusters that form in the cytosol of quiescent cells (58). PSGs are
proposed to form by liquid–liquid phase separation (59), but the
multivalent “molecular glue” that drives PSG condensation has
not been identified. Proteomic analysis of isolated PSGs found
that these compartments are primarily composed of proteasomes
and monoubiquitin (60). Whether monoubiquitin can mediate the
phase separation of proteasomes remains to be tested. Unlike the
degradation microcompartments described in our study, PSGs are
proposed to store inactive proteasomes. It will be interesting to
determine whether these two non–membrane-bound compartments,
which perform different functions, share a common mechanism
of proteasome clustering.
Several properties of the degradation microcompartments
are consistent with liquid–liquid phase separation. The micro-
compartments concentrate specific components (proteasomes
and Cdc48) while excluding others (ribosomes) (Fig. 4). The
microcompartments are spherical at the resolution of light mi-
croscopy (Fig. 1 and SI Appendix, Figs. S3 and S4), and the dense
but disorganized packing of proteasomes (SI Appendix, Fig. S7 and
Movie S3) is reminiscent of the packing of Rubisco within the
liquid-like pyrenoid (61). Furthermore, the microcompartments
appear to readily fuse with each other upon contact (SI Appendix,
Fig. S4 and Movie S2). Fusion has been described for a variety of
liquid-like compartments, including P-granules (62), stress gran-
ules (63), nucleoli (64), and heterochromatin (65). The ability of
two compartments to fuse is a hallmark of liquid–liquid phase
separation and distinguishes a liquid from a gel (66). Additional
evidence for a liquid phase can be established by observing in-
ternal mixing after photobleaching half of a phase-separated
compartment (61, 62, 65). However, this approach may not be
feasible for the degradation microcompartments due to their small
∼200-nm size. During the activation of transmembrane receptors,
including nephrin and T cell receptor, the clustering of membrane
proteins into domains spanning hundreds of nanometers is cou-
pled to the liquid–liquid phase separation of their cytosolic binding
partners (67, 68). It is believed that coupled phase separation
between the membrane and cytoplasm may represent a general
principle in cellular organization (69). We propose that similar
forces drive the clustering of membrane proteins within distinct
ER domains that contact the cytosolic microcompartments of
proteasomes and Cdc48.
Methods
Cell Culture. For fluorescence imaging, proteomics, and in situ cryo-ET, we
used mat3-4 (strain CC-3994) (70) Chlamydomonas reinhardtii cells, provided
by the Chlamydomonas Resource Center (University Minnesota, Minneapolis,
MN). This strain has smaller cells, which greatly improves vitrification by
plunge freezing. Cells were grown in Tris–acetate–phosphate (TAP) medium
under constant light conditions (∼90 μmol photons·m−2·s−1) and normal at-
mosphere. Cells were harvested when they reached midlog phase.
Expression of Fluorescently Tagged Rpn11 in Chlamydomonas. We chose to
fluorescently tag the proteasome cap’s Rpn11 subunit because it has
previously been GFP-tagged without discernable impacts on cellular
function in both budding yeast and fission yeast (71). We cloned into the
pLM005 vector because this tool has successfully been used to localize over
100 different proteins in Chlamydomonas cells to produce a spatial inter-
actome (72). The pLM005-Rpn11 construct (Rpn11 tagged at its C terminus
with mVenus-3xFLAG) was generated by PCR amplification of the full-length
RPN11 sequence from purified genomic DNA (forward primer, 5′-GCTACT-
CACAACAAGCCCAGTTATGGACGGCTTGCAGCGCATGTT-3′; reverse primer,
5′-GAGCCACCCAGATCTCCGTTGAAGACCACCGTGTCCAGCATGG-3′). The PCR
product was then subcloned into the pLM005 vector (Chlamydomonas Re-
source Center, University of Minnesota) (72) using a Gibson assembly kit (NEB)
according to the manufacturer’s instructions. The plasmid was sequenced to
confirm correct insertion of the RPN11 gene (pLM005 forward primer,
oMJ237, 5′-GGAGGTACGACCGAGATGGCT-3′; pLM005 reverse primer,
oMJ555, 5′-CACGTCGCCGTCCAGCTC-3′). Following a transformation protocol
adapted from Zhang et al. (73), the pLM005-RPN11 plasmid was linearized
with the DraI restriction enzyme (NEB) and electroporated into mat3-4 cells.
Transformants were screened on TAP plates supplemented with 20 μg/mL
paromomycin and verified by Western blot using an antibody against the
FLAG tag. To improve Rpn11-mVenus expression, we reselected the same
transformants using TAP plates containing 20 μg/mL paromomycin, and then
grew the cells in liquid TAP media containing 20 μg/mL paromomycin prior to
imaging. Rpn11-mVenus expression did not affect the growth rate of the
cells. The nuclear localization of Rpn11-mVenus (Fig. 1A) indicates that this
Fig. 6. Molecular architecture of non–membrane-bound degradation
microcompartments at the ER. Proteasomes (red) and Cdc48 (yellow) cluster
together to form concentrated ∼200-nm microcompartments that exclude
cytosolic ribosomes (light blue) (Fig. 4 and SI Appendix, Figs. S6 and S7).
These microcompartments directly contact small patches on the rough ER
membrane (gray) that are devoid of membrane-bound ribosomes (dark
blue) and may be enriched in ERAD substrates. The proteasomes closest to
the membrane have regulatory caps that are in the substrate-processing
conformation and are engaged at their substrate-binding sites with densi-
ties emanating from the ER (Fig. 5 and SI Appendix, Fig. S13). Thus, these
densities are likely substrates that are undergoing removal from the ER di-
rectly by proteasomes (a noncanonical pathway we term “direct ERAD”).
Cdc48 complexes are enriched at the microcompartment periphery, where
they may be handing substrates to the proteasomes in the final step of the
canonical ERAD pathway. Unlike proteasomes, Cdc48 is commonly found all
along the ER membrane (82% of ER-proximal proteasomes, but only 20% of
ER-proximal Cdc48, are localized to the microcompartments). Therefore,
Cdc48 might extract substrates from the ER, then diffuse through the cytosol
until it encounters a proteasome, the majority of which are clustered in
microcompartments. Cytosolic diffusion of Cdc48, followed by substrate
hand-off to proteasomes, could explain the peripheral localization of Cdc48
around the proteasome clusters. The microcompartments may additionally
serve as degradation centers for cytosolic proteins. The microcompartments
are positioned away from the larger ribosome-free region of the ER where
COPII-coated vesicles bud en route to the Golgi. This spatially segregates the
ERAD and secretory pathway machinery, and may aid in sorting ER proteins
between trafficking and degradation.

























transgenically expressed protein was incorporated into functional protea-
somes, as this localization has previously been described by in situ cryo-ET (5).
Live-Cell Fluorescence Imaging. Cells from log-phase cultures were immobi-
lized for 15 min on glass bottom u-Slide 8-well micro plates (Ibidi) that were
coated with 5 mM poly-L-lysine. Excess culture was washed away with TAP
medium. For the inhibitor experiments (SI Appendix, Fig. S14), single liquid
cultures were split into batches that were treated with either 50 μM MG132
(Sigma-Aldrich; 474787), 5 μg/mL tunicamycin (Sigma-Aldrich; T7765), or
5 μg/mL NMS-873 (Sigma-Aldrich; SML1128) for 2 h. During the final 10 min,
cells were immobilized on slides and then washed with TAP media containing
the same concentration of inhibitor. All inhibitor tests were performed twice,
each time with a freshly grown culture.
Imaging was performed on a Leica DMI6000 B inverted microscope,
equipped a with coolLED pe-4000 LED source and a Leica DFC9000 GT sCMOS
camera, and operated with LAS X software (Leica Microsystems). The Z stacks
in Fig. 1 were acquired using an HCX PL APO 63×/1.20 numerical aperture
(N.A.) water-immersion objective, whereas the time series in SI Appendix,
Figs. S3 and S4 (Movies S1 and S2) were acquired with a 63×/1.4 N.A.
oil-immersion objective and a hardware infrared autofocus system. The fol-
lowing fluorescence settings were used: mVenus, 500-nm excitation, 535/30-nm
emission filter; chlorophyll autofluorescence, 635-nm excitation, 680/40-nm
emission filter. For the higher-fidelity imaging in Fig. 1, we acquired Z
stacks composed of 38 to 48 slices 0.3 μm apart, covering much more than
the full cellular volume to aid deconvolution. For the time series in SI Ap-
pendix, Figs. S3 and S4, we acquired Z stacks of 20 slices, 0.4 μm apart, every
1 min for 15 cycles. These parameters were selected as a balance between
covering the full cellular volume and minimizing photobleaching. The data
were acquired in 4 imaging sessions: 2 for the quantification of puncta (Fig.
1) and 2 for the time series (SI Appendix, Figs. S3 and S4).
Fluorescence Image Analysis. Z stacks were deconvolved using Huygens Es-
sential software (Scientific Volume Imaging). All further image processing and
analysis were performed with Fiji software (74). Cells and cytosolic puncta
were manually counted using entire Z stacks. Fluorescence intensity of the
nuclear envelope was calculated by averaging the signal of the mVenus
channel from 2 nonoverlapping regions of interest (ROIs) drawn on the center
slice of the nuclear envelope. Similarly, the average intensity of the center 4
pixels was measured individually for every punctum using the signal from a
single slice. For both the nuclear envelope and cytosolic puncta, fluorescence
intensity was internally normalized to the intensity of the mVenus background
signal measured by an ROI drawn in the cytosol of each cell.
Cell Vitrification and Cryo-FIB Milling. Both vitrification and FIB milling pro-
tocols were performed as previously reported (23, 75). Using a Vitrobot Mark
4 (FEI Thermo Fisher), the cell culture (4 μL of ∼1,000 cells per μL) was blotted
onto R2/1 carbon-coated 200-mesh copper EM grids (Quantifoil Micro Tools)
and plunge-frozen in a liquid ethane/propane mixture. Cryo-FIB sample
preparation was performed in either a Scios or Quanta dual-beam FIB/SEM
instrument (FEI Thermo Fisher). Mounted in an Autogrid support, the grids
were first coated with an organometallic platinum layer using a gas injection
system. Subsequently, the cells were milled with a gallium ion beam to
produce ∼100- to 200-nm-thick lamellas, exposing the cellular interior.
Cryo-ET. EM grids containing lamellas were transferred into a 300-kV Titan
Krios microscope (FEI Thermo Fisher), equipped with a postcolumn energy
filter (Gatan) and a K2 Summit direct detector camera (Gatan). Using SerialEM
software (76), tilt series were acquired with 2° steps between −60° and +60°
(in two halves, separated at −0° or −20°). Individual tilts were recorded in
movie mode at 12 frames per second, at an object pixel size of 3.42 Å and a
defocus of −4 to −5.5 μm. The total accumulated dose for the tilt series was
kept below ∼100 e−/Å2. Each tomogram was acquired from a separate cell
and thus is both a biological and technical replicate. Several different cell
cultures and >10 imaging sessions were used to produce the dataset.
Tomogram Reconstruction. Prior to reconstruction, the raw frames from the
K2 detector were drift corrected with MotionCor2 software (77) using 3 × 3
patches, and then tilt-series stacks were assembled. Using IMOD software
(78), the tilt-series were aligned with patch tracking and reconstructed with
weighted backprojection to generate tomographic volumes. We used strin-
gent quality control criteria including tilt-series alignment scores and the
power spectra of individual tilts to, first, omit poor tilts from tomograms and,
second, remove full tomograms from the dataset. Proteasomes, Cdc48, and
ribosomes were extracted from 76, 14, and 6 tomograms, respectively.
Contrast enhancement for display (Fig. 2) was performed with the tom_deconv
deconvolution filter (https://github.com/dtegunov/tom_deconv).
Tomogram Visualization and Segmentation. Slices through tomogram volumes
(Fig. 2 A–C) were generated with the IMOD 3dmod viewer. Tomogram
segmentation (Fig. 2D) was performed in Amira software (FEI Thermo Fisher),
with the help of automated membrane detection from the TomoSegMemTV
package (79). The 3D cellular volumes with mapped-in complexes (Figs. 2D, 4
A and B, and 5C and SI Appendix, Figs. S6 and S7) were displayed in Uni-
versity of California, San Francisco (UCSF) Chimera (80).
Template Matching. Proteasomes, Cdc48, and ribosomes were template
matched (81) in twice-binned tomograms (13.68-Å pixel size) by searching
with down-filtered structures using PyTom software (82). Cytosolic protea-
somes were used from the dataset acquired in ref. 5. All templates were
based on single-particle cryo-EM structures (Electron Microscopy Data Bank:
EMD-2594, EMD-3326, and EMD-2858) (30, 83, 84), down-filtered to 40 Å.
The proteasome template was constructed by masking one cap from the
double-capped proteasome structure, yielding accurate hits for both single-
and double-capped proteasomes. The ribosome template was constructed
by masking the ribosome structure’s small subunit, enabling the subsequent
sorting of true hits from false positives. Following template matching, peak
extraction by cross-correlation delivered a first set of possible candidates,
which were screened with either classification in the case of ribosomes, or
visual inspection for proteasomes and Cdc48. Ribosomes were classified by
constrained PCA (CPCA) (85) for recovery of the small subunit that was
omitted from the template, enabling us to discard noise and false picks.
Subtomogram Averaging and Classification. After the presorting described
above, initial alignment of unbinned subtomograms (3.42-Å pixel size) was
performed in PyTom software, using global alignment with spherical har-
monics (86) to get a first estimate of the angles and shifts for proteasomes,
Cdc48, and ribosomes. Proteasomes and Cdc48 were further refined with
several rounds of real-space alignment and classification in PyTom and
RELION (87), as described in ref. 5 for proteasomes and below for Cdc48.
Refinement in RELION included internal normalization and contrast transfer
function (CTF) correction with CTFFIND4 (88). PyTom subtomogram averages
were instead corrected for CTF in IMOD. Resolution for proteasome and
Cdc48 averages was determined in RELION by gold-standard Fourier shell
correlation, whereas the ribosome resolution was estimated by cross-
correlation with the highly resolved single-particle structure that was used
for template matching (EMD-2858) (84) (SI Appendix, Fig. S9 B–D).
Several rounds of classification were performed to improve structural
homogeneity and distinguish between various conformational states.
Membrane-bound ribosomes were selected from the total cytosolic pop-
ulation with a distance restraint from the ER and nuclear membranes and
subsequent classification of subvolumes with CPCA, as described in ref. 37.
Using PyTom, proteasomes were sorted into single- or double-capped
structures and ground- or processing-state caps, as described in ref. 5. Cdc48
complexes from all tomogram were classified in RELION using 6-fold symme-
try. Several rounds of iterative classification using 2 to 3 classes resulted in a
well-resolved “high-quality” class that resembled the single-particle cryo-EM
structure (SI Appendix, Fig. S10). High-quality Cdc48 particles from the tomo-
grams without proteasome clusters were combined with all Cdc48 candidates
from the cluster tomograms for another round of classification; increasing
number of well-resolved particles in the classification enabled reliable determi-
nation of Cdc48 within the cluster tomograms. The identity of Cdc48 was further
confirmed by calculating a reference-free average, starting from a sphere of
randomly aligned particles. This alignment was successfully performed both
unsymmetrized (SI Appendix, Fig. S11) as well as with 6-fold symmetry (SI Ap-
pendix, Fig. S9). Although the unsymmetrized average resembled a mix of ring
and staircase confirmations (SI Appendix, Fig. S12), no further reliable classi-
fication of Cdc48 was possible due to the small size of the complex (540 kDa).
Fitting Molecular Models into EM Densities. In order to visualize the extra
density bound to the ER-associated proteasomes in Fig. 5B, a molecular
model of the S1 ground-state proteasome (83) was fit into the EM density of
the respective subtomogram average by rigid-body fitting in UCSF Chimera
(89). Molecular models of the yeast 26S proteasome (PDB-5MP9) (90), human
Cdc48/p97 (PDB-5FTK) (31), and yeast 80S ribosome (PDB-3J78) (91) de-
termined by single-particle cryo-EM were also fit into their respective sub-
tomogram averages using rigid-body fitting in UCSF Chimera (SI Appendix,
Fig. S9 B–D).
































Clustering Behavior of Proteasomes and Cdc48. We calculated pairwise dis-
tances between all of the cytosolic proteasomes in the tomograms. We then
randomly placed the same number of proteasomes into the same cytosolic
volumes (masked in Amira software to exclude the volumes of vesicles and
organelles) while avoiding overlap, and again calculated the pairwise dis-
tances. The real data showed a clear peak at short distances that was absent
from the random simulated data, revealing strong clustering behavior (SI
Appendix, Fig. S8A). To define which proteasomes are within ER-associated
clusters, the cytosolic proteasomes were divided into a varying number of
groups using the k-means algorithm, and the quality of the fit was evaluated.
Based on the local maximum of this distribution, we defined the proteasome
population belonging to each cluster.
To determine whether Cdc48 clusters along with the proteasomes, we
calculated the distances between every proteasome to every cytosolic Cdc48
(Fig. 4E). This calculation was performed independently for cluster and
noncluster proteasomes, measuring to both the experimentally determined
Cdc48 positions and also simulated data where Cdc48 complexes were ran-
domly placed throughout the same cytosolic volumes (again, excluding
vesicles and organelles). Whereas there was no significant difference be-
tween the real and random Cdc48 positions for noncluster proteasomes, the
cluster proteasomes had a strong peak at <200 nm when measuring to the
real Cdc48 positions. Thus, cytosolic Cdc48 has a nonrandom distribution
that correlates with the positions of the clustered proteasomes. The statis-
tical significance of this coclustering was confirmed by calculating the nearest-
neighbor cumulative distribution, showing the distance to the closest Cdc48
for each cluster and noncluster proteasome (SI Appendix, Fig. S8B). Compari-
son of the distributions to a random simulation with a 2-sample Kolmogorov–
Smirnov test supports highly statistically significant clustering. As active pro-
teasomes and Cdc48 cluster together at the ER membrane, we have defined
these distinct cytosolic regions as degradation microcompartments. For the
Cdc48 complexes outside of the microcompartments, the distances between
Cdc48 and the ER membrane were indistinguishable from a random simula-
tion (SI Appendix, Fig. S8D).
As a control, the distances were calculated between every proteasome
(cluster and noncluster) and every cytosolic ribosome (SI Appendix, Fig. S8E).
The distributions were not significantly different for the cluster and noncluster
proteasomes; thus, ribosomes do not cluster with proteasomes at the ER.
Analysis of Degradation Microcompartment Shape and Composition. Protea-
some cluster shapes were evaluated by PCA to determine the eigenvalues for
the first 3 principal components. The averages of the eigenvalues for all
clusters were compared to eigenvalues of model shapes (2D circle and 3D
sphere, Fig. 4C).
To dissect the molecular architecture of the degradation microcompart-
ments, we calculated the concentrations of proteasomes, Cdc48, and ribo-
somes in evenly spaced shells expanding from the centroids of each cluster
(Fig. 4D). The centroid was calculated by averaging all cluster proteasome
positions, while the concentration was determined by counting the number
of particles within the shell and dividing it by the shell’s volume. The shell’s
volume included only the cytosol, excluding the volumes of organelles such
as the ER, Golgi, and mitochondria.
Statistical Analysis of Proteasome Functional States within Degradation
Microcompartments. To test whether proteasomes within 20 nm of the ER
membrane (14 caps, 50% processing state) were significantly more active
than proteasomes in the rest of the ER-associated cluster (159 caps, 17%
processing state), we calculated the probability of randomly drawing 14 caps
that consisted of least 50% processing state from the pool of clustered
proteasome caps further than 20 nm from the ER. To simplify the calculation,
16 unclassifiable proteasome caps (9% of the total population) were neglected.
A numeric calculation of probabilities with and without the unclassifiable caps
showed that this simplification is justified (SI Appendix, Fig. S16). According to
the urn model without replacement and order, the probability was calculated
as follows:
X
k1=7 : 14, k2=7 : 1
PðX1 = k1,X2 = k2Þ =
X












with N1 = 29 (number of processing states > 20 nm); N2 = 130 (number of
ground states > 20 nm); N = 159 (number of caps > 20 nm); n = 14 (number
of caps drawn); k1 = 7:14 (number of drawn processing states); k2 = 1:7
(number of drawn ground states); k1 + k2 = n = 14.
The probability of drawing 14 caps with at least 50% processing state is
only 0.3%. Therefore, we can exclude with high significance that the in-
creased percentage of processing states for proteasomes <20 nm from the ER
membrane is random.
Whole-Cell Mass Spectrometry. Chlamydomonas mat3-4 cells were grown to
midlog phase in the same conditions as for the cryo-ET, pelleted at 1,000 × g
for 5 min, and flash-frozen in liquid nitrogen. The cell pellet was lysed in
3 mL of buffer containing 1% sodium deoxycholate (SDC), 20 mM TCEP, and
40 mM chloroacetamide in 25 mM Tris, pH 8.5. The lysate was heated to
95 °C for 2 min, followed by sonication in a Bioruptor sonicator (Diagnode)
at maximum power (10 cycles of 30-s pulses). The heating and sonication was
repeated once to ensure complete lysis. One hundred microliters of lysate
were mixed with 100 μL of LC-MS grade water, vortexed briefly, and in-
cubated at 37 °C for 30 min. After reduction and alkylation, the samples
were digested overnight with 4 μg of trypsin. Following overnight digestion,
the sample was acidified in a final concentration of 1% trifluoroacetic acid
to precipitate the SDC. The supernatant was then used for purification and
fractionation in a SCX StageTip (92). All three fractions from the purification
were loaded into a 15-cm-long and 75-μm-wide column (New Objective),
packed with 1.9-μm C18 reprosil beads (Dr Maisch GmbH). The peptides were
eluted over a gradient for ∼140 min and directly sprayed into a bench top
orbitrap mass spectrometer (Q Exactive HF; Thermo Fisher) (93). Data-
dependent acquisition was employed, and the top 15 precursors were sub-
jected to HCD-based fragmentation (94). The raw data were processed using
the MaxQuant computational platform, version 1.6.0.15 (95), and searched
against the Chlamydomonas proteome derived from all 19,526 protein-
coding transcripts of the Chlamydomonas genome, version 5.5 (96, 97), us-
ing the Andromeda search engine (98) with initial parent ion mass deviation
of 6 ppm. All identifications were filtered at a 1% false-discovery rate. As a
proxy for protein abundance, intensity-based absolute quantification (iBAQ)
values (99) were generated and used to compare the different protein
complexes within the sample (Fig. 3).
Bioinformatic Identification of Conserved ERAD Components in Chlamydomonas
reinhardtii and Arabidopsis thaliana. Chlamydomonas homologs to the core
ERAD components (SI Appendix, Table S1) present in version 5.5 of the
Chlamydomonas genome (96, 97) were identified by BLAST searches using the
Phytozome platform (100) and the BLAST platform at National Center for
Biotechnology Information (NCBI) (https://blast.ncbi.nlm.nih.gov/Blast.cgi) us-
ing Saccharomyces cerevisiae, Homo sapiens, and Arabidopsis thaliana protein
sequences as queries. All homologs were confirmed by manual sequence
alignment to confirm the conservation of functional protein domains. Domain
composition was determined with the Simple Modular Architecture Research
Tool (http://smart.embl-heidelberg.de). For Cue1-like proteins, the full SMART
annotation of the Cue domain included a list of all proteins containing a Cue
domain. Only one Arabidopsis protein contained a single Cue domain with
no additional functional domains; this sequence was used as a query to
identify the matching Chlamydomonas protein. A BLAST search using the
yeast Cue1 and human CueD1 proteins failed to identify a similar protein
in Chlamydomonas or Arabidopsis.
Seed Extension by GRAbB. To resolve some of the gene models encoding
proteins with large low-complexity stretches, we performed a local, seeded
de novo assembly from RNA-sequencing (RNA-seq) reads with the program
GRAbB (101). RNA-seq reads came from run SRR2132411 from the Short
Read Archive SRA at NCBI, from a diurnal time course, 10 h into the light
part of the day (102). Briefly, we chose as seed a sequence with good read
coverage that did not overlap with any dubious part of the gene model.
GRAbB identified all reads mapping to the seed and assembled them into a
new seed for the next iterative round.
For NPL4 (Cre06.g293051), the current gene model encodes a protein with
similarity to an ammonium transporter at its N terminus, and a protein with 2
NPL4 domains at its C terminus. However, the gene model tries to accom-
modate a gap in sequence of about 5,000 bp, in addition to low-complexity
sequences on either side of the gap. We used 918 bp downstream of the gap
as the seed. After 5 rounds of extension, GRAbB assembled reads into a final
1,683 bp in silico cDNA encoding a protein of 426 amino acids with 3 Npl44-
like domains (SI Appendix, Fig. S2).
For HRD1 (Cre04.g217922), we used a 729-bp seed that mapped to the
penultimate exon, upstream of a transposon-like element in the last intron.
After 8 rounds, GRAbBassembled reads into a 1,121-bp in silico cDNA, encoding
a 333-amino acid protein that includes the 6 transmembrane domains and the
RING domain. The position of the STOP codon is supported by PASA-assembled

























expressed sequence tags (103); the gene model should therefore not include
the 3′ end encoding the C-terminal low-complexity region.
For Cue1 (Cre13.g568750), we used a 128-bp seed corresponding to the
Cue domain. After 5 rounds, GRAbB assembled reads into a 543-bp in silico
cDNA, encoding a 181-amino acid protein that lacksmost of the low-complexity
regions found in the current gene model.
For EDEM1 (Cre06.g301600), we used a 2,052-bp seed that covers the
entire mannosidase-encoding portion of the gene. After 5 rounds, GRAbB
assembled reads into a 2,320-bp in silico cDNA, encoding a 732-amino acid
protein consisting of a signal peptide at its N terminus, the mannosidase
domain (used as seed), and a small low-complexity region at its C terminus.
Data Availability: Subtomogram averages and an example tomogram have
been deposited in the Electron Microscopy Data Bank (EMD-3932 to EMD-3935
and EMD-10409 to EMD-10411). Mass spectrometry data have been deposited
in the PRIDE archive (PXD009375).
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